The United Kingdom anti-rheumatic market
The United Kingdom anti-rheumatic market size is forecast to grow from approximately USD 5.25 Billion in 2025 to around USD 7.75 Billion by 2035. According to Decision Advisors, a detailed research report on the anti-rheumatics market indicates that the rising adoption of biologics and biosimilars trend dominates the market, accounting for approximately 40-45% of the total share in the United Kingdom. AbbVie Inc. leads the market with an estimated 20% United Kingdom market share. The company\'s annual revenue of approximately USD 54 billion is making it one of the most influential forces shaping industry trends and overall market growth.